Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
about
Context-dependent associations between variation in risk of ischemic heart disease and variation in the 5' promoter region of the apolipoprotein E gene in Danish women.Subsets of SNPs define rare genotype classes that predict ischemic heart disease.Variation in 5' promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart StudyImpact of psychological stress on the associations between apolipoprotein E variants and metabolic traits: findings in an American sample of caregivers and controls.Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart diseaseK45R variant of squalene synthase increases total cholesterol levels in two study samples from a French Canadian population.
P2860
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@ast
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@en
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@nl
type
label
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@ast
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@en
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@nl
prefLabel
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@ast
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@en
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@nl
P2093
P2860
P50
P1476
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
@en
P2093
Jari H Stengård
Ruth Frikke-Schmidt
Sara C Hamon
P2860
P304
P356
10.1194/JLR.M500491-JLR200
P577
2005-11-29T00:00:00Z